Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 8 for:    progeria
Previous Study | Return to List | Next Study

Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Schering-Plough
Information provided by (Responsible Party):
Mark Kieran, Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT00916747
First received: June 5, 2009
Last updated: December 22, 2015
Last verified: December 2015